Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pediatric genitourinary tumors.

B E Cowan1, L M Shortliffe

  • 1Stanford University School of Medicine, California.

Current Opinion in Oncology
|June 1, 1992
PubMed
Summary
This summary is machine-generated.

Pediatric genitourinary tumors, particularly Wilms' tumor, offer insights into cancer development. Collaborative research and advanced therapies have significantly improved survival rates and reduced treatment side effects for children.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pediatric urinary tract infections.

Pediatric clinics of North America·2001
Same author

The effects of intravesical lidocaine on bladder dynamics of children with myelomeningocele.

The Journal of urology·2001
Same author

Evaluation of sonographic renal parenchymal area in the management of hydronephrosis.

The Journal of urology·2001
Same author

Evaluation and management of pediatric urinary tract infections.

The Urologic clinics of North America·1999
Same author

Progressive renal shrinkage after simple pyelonephritis.

Urology·1998
Same author

Oxybutynin decreases renal pelvic pressures in normal and infected rat urinary tract.

The Journal of urology·1998
Same journal

Artificial intelligence-augmented robotic surgery in gynecologic oncology: intraoperative assistance and analytics.

Current opinion in oncology·2026
Same journal

Artificial intelligence in cervical cancer screening and triage: a role-stratified systematic review and bivariate meta-analysis.

Current opinion in oncology·2026
Same journal

Deep learning assisting the surgical management of gynecologic cancers.

Current opinion in oncology·2026
Same journal

Pain management in pancreatic cancer: time to change our strategy!

Current opinion in oncology·2026
Same journal

Systemic radionuclide treatments in gastro-entero-pancreatic neuroendocrine tumours.

Current opinion in oncology·2026
Same journal

5-Fluorouracil at seventy: still attractive but barely understood. A cautionary tale for drug development.

Current opinion in oncology·2026
See all related articles

Area of Science:

  • Pediatric oncology
  • Genitourinary oncology
  • Cancer developmental biology

Background:

  • Genitourinary tumors represent 10% of childhood cancers, with Wilms' tumor being the most prevalent.
  • The study of these rare pediatric cancers has provided a valuable model for understanding cancer development.
  • Historically, treatment for these cancers faced challenges in survival and morbidity.

Purpose of the Study:

  • To highlight the significance of genitourinary tumors in pediatric oncology research.
  • To emphasize the impact of collaborative research on improving patient outcomes.
  • To showcase the advancements in understanding and treating these complex childhood cancers.

Main Methods:

  • Review of interinstitutional and international research collaborations.

Related Experiment Videos

  • Analysis of advancements in molecular biology and experimental techniques.
  • Evaluation of the application of multi-modality therapy in clinical practice.

    • Main Results:

    • Collaborative efforts have led to improved survival rates for children with genitourinary tumors.
    • Treatment-related morbidity has been significantly reduced.
    • Ongoing discoveries in molecular biology are routinely enhancing the field.

    Conclusions:

    • The study of pediatric genitourinary tumors has established a critical model for cancer research.
    • Multi-modality therapy, driven by research advancements, has saved thousands of children's lives.
    • The field remains dynamic, with continuous improvements in diagnosis and treatment.